Physician

Imran Sajjad, MD

According to 2025 Medicare claims, Imran Sajjad, MD (NPI: 1942255849) practices internal medicine in the Milwaukee-Waukesha, WI market, with the plurality of this provider's patient population coming from Waukesha, WI. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES SC (NPI: 1871679514; TIN: 391717839) and primary practice location at 53186-5974. Sajjad is affiliated with the ProHealth Solutions, LLC (ACO ID: A4979) and SSM WI ACO LLC (ACO ID: A5124), participating under the MSSP model.

Sajjad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 828 traditional Medicare patients, billed 12,057 HCPCS/CPT codes, and received $310,628 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 5,064 prescription claims across 876 beneficiaries totaling $368,147 in drug costs, led by Jardiance (Empagliflozin). 2023 DME data shows 44 claims. Open Payments data shows 10 records totaling $444. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $220,781 to $368,147. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	705	3,638	$281,705
2016	654	3,237	$262,543
2017	687	2,878	$232,466
2018	712	3,106	$243,978
2019	708	2,866	$215,523
2020	752	3,289	$231,511
2021	969	6,919	$323,732
2022	929	4,396	$292,643
2023	856	7,541	$280,551
2024	828	12,057	$310,628

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	264	1,913	$220,781
2016	313	2,215	$254,806
2017	354	1,951	$212,801
2018	383	2,048	$143,912
2019	427	2,357	$181,160
2020	487	2,720	$197,809
2021	691	3,679	$244,513
2022	801	4,371	$364,377
2023	836	4,475	$291,809
2024	876	5,064	$368,147

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	23	$399
2021	N/R	N/R	N/R
2022	N/R	24	$286
2023	N/R	44	$357
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	130	141	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	79	117	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	452	804	$58
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	255	722	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	383	682	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	79	5,009	$98,331
Tymlos	Abaloparatide	13	630	$55,410
Farxiga	Dapagliflozin Propanediol	45	2,380	$43,488
Lokelma	Sodium Zirconium Cyclosilicate	23	1,436	$19,962
Prosol	Parenteral Amino Acid 20% No.1	39	268	$13,970

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$444	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Imran Sajjad, MD?

Tedicare shows public-source Medicare data for Imran Sajjad, MD (NPI 1942255849), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Imran Sajjad, MD have ACO affiliation data?

Imran Sajjad, MD is shown with ACO affiliation data for ProHealth Solutions, LLC (MSSP, ACO ID A4979) and SSM WI ACO LLC (MSSP, ACO ID A5124).

What billing organization is linked to Imran Sajjad, MD?

Imran Sajjad, MD is linked to NEPHROLOGY ASSOCIATES SC (billing NPI 1871679514) in the available physician profile data.

Does Imran Sajjad, MD have Open Payments data?

Imran Sajjad, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.